125 related articles for article (PubMed ID: 36929985)
1. Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch).
Geismar C; Nguyen V; Fragaszy E; Shrotri M; Navaratnam AMD; Beale S; Byrne TE; Fong WLE; Yavlinsky A; Kovar J; Braithwaite I; Aldridge RW; Hayward AC; White P; Jombart T; Cori A
Lancet; 2022 Nov; 400 Suppl 1():S40. PubMed ID: 36929985
[TBL] [Abstract][Full Text] [Related]
2. Bayesian reconstruction of SARS-CoV-2 transmissions highlights substantial proportion of negative serial intervals.
Geismar C; Nguyen V; Fragaszy E; Shrotri M; Navaratnam AMD; Beale S; Byrne TE; Fong WLE; Yavlinsky A; Kovar J; Hoskins S; Braithwaite I; Aldridge RW; Hayward AC; White PJ; Jombart T; Cori A
Epidemics; 2023 Sep; 44():100713. PubMed ID: 37579586
[TBL] [Abstract][Full Text] [Related]
3. Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.
Xu X; Wu Y; Kummer AG; Zhao Y; Hu Z; Wang Y; Liu H; Ajelli M; Yu H
BMC Med; 2023 Sep; 21(1):374. PubMed ID: 37775772
[TBL] [Abstract][Full Text] [Related]
4. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data.
Manica M; Litvinova M; De Bellis A; Guzzetta G; Mancuso P; Vicentini M; Venturelli F; Bisaccia E; Bento AI; Poletti P; Marziano V; Zardini A; d'Andrea V; Trentini F; Bella A; Riccardo F; Pezzotti P; Ajelli M; Giorgi Rossi P; Merler S;
Epidemiol Infect; 2022 Dec; 151():e5. PubMed ID: 36524247
[TBL] [Abstract][Full Text] [Related]
6. Household serial interval of COVID-19 and the effect of Variant B.1.1.7: analyses from prospective community cohort study (Virus Watch).
Geismar C; Fragaszy E; Nguyen V; Fong WLE; Shrotri M; Beale S; Rodger A; Lampos V; Byrne T; Kovar J; Navaratnam AMD; Patel P; Aldridge RW; Hayward A;
Wellcome Open Res; 2021; 6():224. PubMed ID: 34796276
[No Abstract] [Full Text] [Related]
7. Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission.
Manica M; De Bellis A; Guzzetta G; Mancuso P; Vicentini M; Venturelli F; Zerbini A; Bisaccia E; Litvinova M; Menegale F; Molina Grané C; Poletti P; Marziano V; Zardini A; d'Andrea V; Trentini F; Bella A; Riccardo F; Pezzotti P; Ajelli M; Giorgi Rossi P; Merler S;
Lancet Reg Health Eur; 2022 Aug; 19():100446. PubMed ID: 35791373
[TBL] [Abstract][Full Text] [Related]
8. Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants.
Madewell ZJ; Yang Y; Longini IM; Halloran ME; Vespignani A; Dean NE
BMC Infect Dis; 2023 Jun; 23(1):429. PubMed ID: 37365505
[TBL] [Abstract][Full Text] [Related]
9. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
[TBL] [Abstract][Full Text] [Related]
10. Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2.
Park SW; Sun K; Abbott S; Sender R; Bar-On YM; Weitz JS; Funk S; Grenfell BT; Backer JA; Wallinga J; Viboud C; Dushoff J
Proc Natl Acad Sci U S A; 2023 May; 120(22):e2221887120. PubMed ID: 37216529
[TBL] [Abstract][Full Text] [Related]
11. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
Hakki S; Zhou J; Jonnerby J; Singanayagam A; Barnett JL; Madon KJ; Koycheva A; Kelly C; Houston H; Nevin S; Fenn J; Kundu R; Crone MA; Pillay TD; Ahmad S; Derqui-Fernandez N; Conibear E; Freemont PS; Taylor GP; Ferguson N; Zambon M; Barclay WS; Dunning J; Lalvani A;
Lancet Respir Med; 2022 Nov; 10(11):1061-1073. PubMed ID: 35988572
[TBL] [Abstract][Full Text] [Related]
12. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis.
Hart WS; Miller E; Andrews NJ; Waight P; Maini PK; Funk S; Thompson RN
Lancet Infect Dis; 2022 May; 22(5):603-610. PubMed ID: 35176230
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England.
Perez-Guzman PN; Knock E; Imai N; Rawson T; Elmaci Y; Alcada J; Whittles LK; Thekke Kanapram D; Sonabend R; Gaythorpe KAM; Hinsley W; FitzJohn RG; Volz E; Verity R; Ferguson NM; Cori A; Baguelin M
Nat Commun; 2023 Jul; 14(1):4279. PubMed ID: 37460537
[TBL] [Abstract][Full Text] [Related]
14. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit JD; Gómez-Olivé FX; Dawood FS; Mkhencele T; Sun K; Viboud C; Tempia S;
Lancet Infect Dis; 2022 Jun; 22(6):821-834. PubMed ID: 35298900
[TBL] [Abstract][Full Text] [Related]
16. Estimating the serial intervals of SARS-CoV-2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong.
Guo Z; Zhao S; Yam CHK; Li C; Jiang X; Chow TY; Chong KC; Yeoh EK
Influenza Other Respir Viruses; 2023 Feb; 17(2):e13105. PubMed ID: 36824395
[TBL] [Abstract][Full Text] [Related]
17. Comparing the incubation period, serial interval, and infectiousness profile between SARS-CoV-2 Omicron and Delta variants.
Guo Z; Zhao S; Mok CKP; So RTY; Yam CHK; Chow TY; Chan TCP; Wei Y; Jia KM; Wang MH; Chong KC; Yeoh EK
J Med Virol; 2023 Mar; 95(3):e28648. PubMed ID: 36892159
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
[TBL] [Abstract][Full Text] [Related]
19. Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea.
Kim D; Ali ST; Kim S; Jo J; Lim JS; Lee S; Ryu S
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336939
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study.
Galmiche S; Cortier T; Charmet T; Schaeffer L; Chény O; von Platen C; Lévy A; Martin S; Omar F; David C; Mailles A; Carrat F; Cauchemez S; Fontanet A
Lancet Microbe; 2023 Jun; 4(6):e409-e417. PubMed ID: 37084751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
